BB Biotech AG : Disclosure pursuant to article 26 sec 1 clause 2 WpHG (own shares) as at January 20, 2015

BB Biotech AG /
BB Biotech AG : Disclosure pursuant to article 26 sec 1 clause 2 WpHG (own 
shares) as at January 20, 2015 
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement. 

Disclosure of shareholding

Pursuant  to  article  26 sec  1 clause  2 WpHG,  BB  Biotech  AG, Schaffhausen,
Switzerland,  herby reports that it increased its  holding in own shares to more
than  5% of the proportion of  voting rights as of  January 16, 2015 (a total of
603 708 shares / 5.09% of the proportion of voting rights).

Thereof, 0.34% of the proportion of voting rights (a total of 41 008 shares) are
held through its wholly-owned subsidiary Biotech Target N.V., Curaçao.



For further information: Bellevue Asset Management AG, Seestrasse 16, 8700
Küsnacht / Zürich

Tanja Chicherio, Tel. +41 44 267 67 00.



Schaffhausen, January 20, 2015

BB Biotech AG



Release (PDF): 
http://hugin.info/136834/R/1888030/668037.pdf



This announcement is distributed by GlobeNewswire on behalf of 
GlobeNewswire clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: BB Biotech AG via GlobeNewswire
[HUG#1888030]